Study of microencapsulated fatty acid antimicrobial activity in vitro and its prevention ability of Clostridium perfringens induced necrotic enteritis in broiler chicken

Nanshan Qi,Shaobing Liu,Fangquan Yan,Bing Chen,Shilin Wu,Xuhui Lin,Zhuanqiang Yan,Qingfeng Zhou,Shenquan Liao,Juan Li,Minna Lv,Haiming Cai,Junjing Hu,Jianfei Zhang,Youfang Gu,Mingfei Sun
DOI: https://doi.org/10.1186/s13099-022-00526-9
2023-01-03
Gut Pathogens
Abstract:Necrotic enteritis (NE) is an infectious intestinal disease caused by Clostridium perfringens ( C. perfringens ) that is now re-emerging and causing concern within the poultry industry. Previously, the supplementation of antibiotics in feed was the most popular control strategy against C. perfringens . However, with the ban on supplementing growth-promoting antibiotics in livestock feed, alternatives to antibiotics will be essential in order to control necrotic enteritis. A possible alternative to antibiotics could be the medium or long chain fatty acids (MCFA or LCFA) as these are able to destroy cell membranes which in turn results in the death of bacteria. In this study, the in vitro antimicrobial activity of different combinations with microencapsulated caprylic acid (C8: 0), capric acid (C10: 0), lauric acid (C12: 0) and myristic acid (C14: 0) against C. perfringens and in vivo control the NE-inducing C. perfringens in broiler chicken were analyzed.
gastroenterology & hepatology,microbiology
What problem does this paper attempt to address?